Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 372 participants.
Also called NCT07668323
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 372 participants
- Registry
-
NCT07668323
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT07668323. Randomized; single masking; primary purpose treatment. Start 2026-09-19 (actual); primary completion 2029-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intra-arterial Thrombolysis For Acute Ischemic Stroke With Medium Vessel Occlusion
- Acronym
- IAT-MEVO
- Condition
- Medium Vessel Occlusion
- Condition
- Ischemic Stroke, Acute
- Intervention (Drug)
- Recombinant Tissue Plasminogen Activator (rt-PA)
- Intervention (Procedure)
- Intra-arterial Thrombolysis
- Intervention (Drug)
- Best Medical Management
- Intervention (Procedure)
- Rescue therapy
- Lead sponsor
- The First Affiliated Hospital with Nanjing Medical University
Record details
- Record id
cardio:ct-nct07668323- Content hash
121c782009182ae2e477b0eda95b99202101db73e936d63bcb501e13177eedbc